Inventiva to Participate in Four Upcoming March Investor Conferences

Daix (France), New York (United States), February 26, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that the Company’s leadership will participate in one-on-one meetings and presentations during the following upcoming investor events:

TD Cowen 46th Annual Health Care Conference – March 2-4, 2026
Date: Monday, March 2, 2026
Time of fireside chat: 10:30am EST
Location: Boston, Massachusetts

Leerink Global Healthcare Conference – March 9-11, 2026
Date: Tuesday, March 10, 2026
Time of presentation: 10:00am EDT
Location: Miami, Florida

Barclays 28th Annual Global Healthcare Conference – March 10-12, 2026
Date: Wednesday, March 11, 2026
Time of fireside chat: 11:00am EDT
Location: Miami, Florida

UBS Biotech Conference: Catalyst for Change – March 8-10, 2026
Location: Miami, Florida

The presentation and fireside chats will be webcast and can be accessed by visiting the Investor Presentations section of the website.

About Inventiva

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of an oral small molecule therapy for the treatment of patients with MASH. The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic liver disease.

Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). https://www.inventivapharma.com

Contacts

Attachment

• Inventiva - PR - Investor Conferences March - EN - 02 25 2026

You May Also Be Interested In

• Lerøy Seafood Group ASA: Primary Insider Transaction
• Battery X Metals Provides Board of Directors Update
• Dr. Ahlem Arfaoui Recognized with the Best Author on Election Law and Reform in New York of 2026 Award, Announces Release of The Power of the Political Contribution in the United States, a New Analysi